Evaluating the risk of dapsone hypersensitivity syndrome in Nepalese Leprosy Patients via HLA-B* 13:01 screening using real-time PCR and comparative meta-analysis of international data
{{output}}
Background: Dapsone Hypersensitivity Syndrome (DHS) is a serious debilitating condition which can develop after 2-8 weeks of dapsone treatment in varying proportions between genetically diverse populations. Approximately 10% of t... ...
